Mr. Guindo will oversee the development and implementation of the company’s long-term strategy for the Human Health portfolio, spanning across oncology, vaccines, pharmaceutical and pipeline products, according to a June 21 press release.
Mr. Guindo will step into the chief marketing officer role on July 1 and will report to Robert Davis, CEO and president of Merck.
Prior to his role at Merck, Mr. Guindo served as executive vice president and head of global product strategy and commercialization at biotechnology company Biogen.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
